Published in Cancer Weekly, November 9th, 2004
According to a study from Taiwan, "Paclitaxel has significant antitumor activity in several human tumors, including Kaposi sarcoma (KS). Human herpesvirus 8 (HHV-8) is implicated in all forms of Kaposi sarcoma, primary effusion lymphoma (PEL), and multicentric Castleman disease (MCD), indicating that it is a DNA tumor virus.
"Since it is difficult to culture cell lines derived from KS patients, we used a cell line derived from PEL (BCBL-1) to investigate whether oxidative stress is involved in the cytotoxicity of paclitaxel on the HHV-8-related tumors."
...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2004-11-09)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.